Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease
Marie‐Laure Boof(Idorsia (Switzerland)), Mike Ufer(Idorsia (Switzerland)), Peter Heymer(Technische Universität Dresden), Ingo Fietze(Humboldt-Universität zu Berlin), Mareile Brunke(Research Institute for Philosophy Hannover), Jasper Dingemanse(Actelion (Switzerland)), Olaf Kestermann(Klinikum Rheine), Katharina Lederer(Charité - Universitätsmedizin Berlin), Albert Esselmann
Cited by 27
Related Papers
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Prevalence and association analysis of obstructive sleep apnea with gender and age differences – Results of SHIP‐Trend
|Journal of Sleep Research|2018|396
Non-CPAP therapies in obstructive sleep apnoea
|European Respiratory Journal|2011|379